Wolfgang Fischer
Chief Operating Officer bei AFFIMED N.V.
Vermögen: 573 704 $ am 31.03.2024
Profil
Wolfgang Fischer is currently the Chief Operating Officer at Affimed NV and Affimed GmbH.
He previously worked as the Regional Medical Director-Hematology at Novartis Pharma Schweiz AG.
He holds a doctorate degree from the Swiss Federal Institute of Technology and the University of Würzburg Medical School.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
AFFIMED N.V.
0,72% | 15.03.2023 | 108 246 ( 0,72% ) | 573 704 $ | 31.03.2024 |
Aktive Positionen von Wolfgang Fischer
| Unternehmen | Position | Beginn |
|---|---|---|
| AFFIMED N.V. | Chief Operating Officer | 13.09.2017 |
Affimed GmbH
 Affimed GmbH Miscellaneous Commercial ServicesCommercial Services Part of Affimed NV, Affimed GmbH is a clinical leader in innate immuno-oncology. The private company, based in Heidelberg, Germany, develops proprietary cancer-targeting bispecific antibodies that activate the innate immune system to kill tumor cells. Affimed leads clinical development of innate cell engagers for solid/hematologic tumors as monotherapy, in combination with NK cells or with checkpoint inhibitors. Adolf Hoess has been the CEO of the German company since 2010. | Chief Operating Officer | 01.01.2017 |
Ehemalige bekannte Positionen von Wolfgang Fischer
| Unternehmen | Position | Ende |
|---|---|---|
Novartis Pharma Schweiz AG
 Novartis Pharma Schweiz AG Miscellaneous Commercial ServicesCommercial Services Novartis Pharma Schweiz AG engages in the marketing and distribution of pharmaceutical, chemical, and medical products of the Novartis group. Its products are used in the treatment of diseases in the areas of neurology, immunology, dermatology, ophthalmology, cardiology, and oncology. The company was founded on December 10, 1986 and is headquartered in Rotkreuz, Switzerland. | Corporate Officer/Principal | - |
Ausbildung von Wolfgang Fischer
| Swiss Federal Institute of Technology | Doctorate Degree |
| University of Würzburg Medical School | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| AFFIMED N.V. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Novartis Pharma Schweiz AG
Novartis Pharma Schweiz AG Miscellaneous Commercial ServicesCommercial Services Novartis Pharma Schweiz AG engages in the marketing and distribution of pharmaceutical, chemical, and medical products of the Novartis group. Its products are used in the treatment of diseases in the areas of neurology, immunology, dermatology, ophthalmology, cardiology, and oncology. The company was founded on December 10, 1986 and is headquartered in Rotkreuz, Switzerland. | Commercial Services |
Affimed GmbH
Affimed GmbH Miscellaneous Commercial ServicesCommercial Services Part of Affimed NV, Affimed GmbH is a clinical leader in innate immuno-oncology. The private company, based in Heidelberg, Germany, develops proprietary cancer-targeting bispecific antibodies that activate the innate immune system to kill tumor cells. Affimed leads clinical development of innate cell engagers for solid/hematologic tumors as monotherapy, in combination with NK cells or with checkpoint inhibitors. Adolf Hoess has been the CEO of the German company since 2010. | Commercial Services |
